Complaint alleging “insider trading by Joublin based on confidential information Joublin obtained while employed at AstraZeneca PLC” in U.S. Securities and Exchange Commission v. Hugues Pierre Joublin, described as a resident of France, at the U.S. District Court for the Southern District of New York.
10
May 27, 2022
Hugues Pierre Joublin
Securities and Exchange Commission
Topics
France Fraud Investment Listed Securities RegulatoryKeywords
AstraZeneca Daiichi Sankyo Hugues Pierre Joublin